Jigsaw Regularization in Whole-Slide Image Classification

arXiv cs.CV / 3/24/2026

📰 NewsSignals & Early TrendsIdeas & Deep AnalysisModels & Research

Key Points

  • The paper studies whole-slide image (WSI) classification for computational pathology, where slide-level labels must be inferred from unlabeled patches using multiple instance learning (MIL).
  • It argues that many MIL methods assume patches are exchangeable and therefore miss the spatial/topological structure inherent in tissue images.
  • The proposed method improves spatial awareness by combining foundation-model embeddings (to encode local structure within patches) with graph neural networks (to model relationships across patches).
  • A key novelty is the introduction of “jigsaw regularization,” a new regularization strategy meant to strengthen across-patch spatial learning in the graph framework.
  • Experiments on breast, head-and-neck, and colon cancer benchmark datasets show the combined approach outperforms prior state-of-the-art attention-based MIL methods.

Abstract

Computational pathology involves the digitization of stained tissues into whole-slide images (WSIs) that contain billions of pixels arranged as contiguous patches. Statistical analysis of WSIs largely focuses on classification via multiple instance learning (MIL), in which slide-level labels are inferred from unlabeled patches. Most MIL methods treat patches as exchangeable, overlooking the rich spatial and topological structure that underlies tissue images. This work builds on recent graph-based methods that aim to incorporate spatial awareness into MIL. Our approach is new in two regards: (1) we deploy vision \emph{foundation-model embeddings} to incorporate local spatial structure within each patch, and (2) achieve across-patch spatial awareness using graph neural networks together with a novel {\em jigsaw regularization}. We find that a combination of these two features markedly improves classification over state-of-the-art attention-based MIL approaches on benchmark datasets in breast, head-and-neck, and colon cancer.